Archives: Speakers

Dr. Harry Kamilaris’ expertise is in sustainable food production and innovation. With a scientific background in animal science, whole farm emissions, and soil carbon, Harry is dedicated to advancing resilient agricultural systems. His background includes carbon accounting and modelling food production systems. At Agricarbon, Harry continues to impact the sector by supporting the dairy industry in quantifying their soil carbon stocks.   

Maria-Cruz Morillo, M.S. Pharmacy, has acquired a deep knowledge of drug development during her 28 years of experience in Project Management and Strategy and IMP Supply in both biotech and CROs. Her design and implementation of effective study protocols has contributed significantly to the successful market authorizations for numerous rare endocrinology and hematology autoimmune programs. Maria-Cruz is currently working as the head of Allucent’s team of Rare Disease experts, integrating cross functional expertise to provide strategic solutions that foster successful outcomes in rare disease clinical trials and ensure excellence in delivery.

Monica Hovsepian, Financial Services lead at OpenText, drives the financial services global strategy and marketing efforts across business solutions. With over 25 years of financial industry expertise, she’s a respected authority and thought leader, having worked with various major banks worldwide, spearheading operational enhancements and customer-centric innovations, including initiatives designed to revitalize the customer experience. An Economics graduate from York University, she holds an MBA from Hult International Business School, London. Monica is also a member of the Forbes Finance Council.

Jake has led experimentation teams for over 10 years and is now head of conversion services at Fresh Egg. His team has delivered huge revenue performance gains for many insurance providers such as Ageas, John Lewis Finance, Agria and Aardy.

His talks draw on his wealth of experience, working across multiple industries, to highlight the biggest opportunities companies can often exploit and the costly mistakes to avoid.

With 17 years of marketing experience Stuart has worked with some of the world’s best-known brands, including many in the financial services sector, supporting and guiding their digital strategy.

Via his role at Webtrends Optimize, he helps companies thrive in their conversion optimisation journeys, often guiding them from inception to mastery.

His talks join the dots often missed by subject specialists with a focus on actionable takeaways rather than theoretical ramblings.

Gary has been working to deliver technology based solutions for businesses for over 25 years. He is a Chartered Management Institute Certified Professional Consultant and Business Analyst with experience of working on multitude of transformation projects.

Gary is currently working within Kainos to help insurers digitally transform to deliver better customer and employee experiences across multiple client projects. With a particular focus on elevating the customer and employee experience in insurance by innovating the claims process using Azure OpenAI.

Richard Gray is a Managing Partner at Dassault Life Sciences, engaged across the full portfolio including the market leading Medidata brand. He has been serving the life sciences & healthcare industry for over 30 years, inspired by the opportunity to accelerate productivity across the value chain and improve outcomes for patients.

With a background in process optimization, data, and technology, he has enabled many European and US sponsors to uplift their capabilities, and in his current role he is driving innovation in areas including early-stage research and discovery, through preclinical and clinical, out to manufacturing, supply chain and commercialisation.

Richard believes that data [strategy] holds the key to accelerating the value of technology, creating the opportunity to connect physical and digital worlds to advance virtual twin experiences, enabling the promise of AI to be democratized, and fueling in silico approaches that will revolutionise the science of tomorrow.

Polly brings her perspective on clinical trials from 34 years of experience in drug development with roles in Research, Early Compound Evaluation, Formulation Development, Resource Management and Clinical phase I – IV. Polly holds an MBA (specializing in Marketing, Finance and Strategy), a Masters Certificate in Project Management from George Washington University and a BSc (hons) in Pharmacology. Energized by the CRO world of constant learning, she is currently part of ICON Biotech since May 2021, where she is supporting sponsor’s outsourcing decisions, listening and interpreting sponsor requirements into successful and enjoyable study delivery.

Robbie has worked directly for several large commodity companies including Fonterra (NZ) as well as consulted in the field of commodity risk management and supply chain planning.

Experienced leader in SaaS, commodity markets, portfolio optimisation, price risk management, and qualitative and quantitative economic analysis.

Proven track record of delivering results through client and stakeholder engagement, tenacity, and thought leading analysis.

Holds undergraduate and postgraduate degrees from the University of Auckland, lectured Economics at the Auckland University of Technology, and served as an auditor for the Foundations of Commodities course at the JP Morgan Business School at the University of Colorado, Denver.